ZA952058B - Use of compounds having an anti-glucocorticoid activity for the preparation of medicaments intended for the prevention or treatment of symptoms associated with the syndrome of spontaneous or precipitated withdrawal from narcotics or narcotic mixtures and the compositions containing them - Google Patents

Use of compounds having an anti-glucocorticoid activity for the preparation of medicaments intended for the prevention or treatment of symptoms associated with the syndrome of spontaneous or precipitated withdrawal from narcotics or narcotic mixtures and the compositions containing them

Info

Publication number
ZA952058B
ZA952058B ZA952058A ZA952058A ZA952058B ZA 952058 B ZA952058 B ZA 952058B ZA 952058 A ZA952058 A ZA 952058A ZA 952058 A ZA952058 A ZA 952058A ZA 952058 B ZA952058 B ZA 952058B
Authority
ZA
South Africa
Prior art keywords
narcotics
spontaneous
syndrome
prevention
compounds
Prior art date
Application number
ZA952058A
Inventor
Francis Petit
Daniel Philibert
Andre Ulmann
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of ZA952058B publication Critical patent/ZA952058B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Addiction (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA952058A 1994-04-08 1995-03-13 Use of compounds having an anti-glucocorticoid activity for the preparation of medicaments intended for the prevention or treatment of symptoms associated with the syndrome of spontaneous or precipitated withdrawal from narcotics or narcotic mixtures and the compositions containing them ZA952058B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9404156A FR2718354B1 (en) 1994-04-08 1994-04-08 Application of the anti-glucocorticoid compounds for the preparation of medicaments intended for the prevention or the treatment of the manifestations linked to the narcotic withdrawal syndrome and the compositions containing them.

Publications (1)

Publication Number Publication Date
ZA952058B true ZA952058B (en) 1996-03-13

Family

ID=9461887

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA952058A ZA952058B (en) 1994-04-08 1995-03-13 Use of compounds having an anti-glucocorticoid activity for the preparation of medicaments intended for the prevention or treatment of symptoms associated with the syndrome of spontaneous or precipitated withdrawal from narcotics or narcotic mixtures and the compositions containing them

Country Status (10)

Country Link
EP (1) EP0676203A1 (en)
JP (1) JPH07278017A (en)
KR (1) KR950031081A (en)
CN (1) CN1116929A (en)
AU (1) AU1632695A (en)
CA (1) CA2146600A1 (en)
FI (1) FI951683A (en)
FR (1) FR2718354B1 (en)
HU (1) HUT71468A (en)
ZA (1) ZA952058B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5929262A (en) * 1995-03-30 1999-07-27 The United States Of America As Represented By The Department Of Health And Human Services Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates
FR2757400B1 (en) * 1996-12-19 1999-12-17 Hoechst Marion Roussel Inc APPLICATION OF ANTIGLUCOCORTICOIDAL COMPOUNDS IN THE TREATMENT OF PSYCHOSIS OR ADDICTIVE BEHAVIORS
EP1862468A1 (en) 2006-06-02 2007-12-05 Bayer Schering Pharma Aktiengesellschaft Crystalline 11beta-(4-acetylphenyl)-20,20,21,21,21-pentafluor-17-hydroxy-19-nor-17alpha-pregna-4,9-dien-3-one
DE102009034367A1 (en) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-benzylidene derivatives, process for their preparation and their use for the treatment of diseases
DE102009034362A1 (en) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-aryl derivatives, process for their preparation and their use for the treatment of diseases
DE102009034368A1 (en) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-acyloxyalkylenephenyl derivatives, process for their preparation and their use for the treatment of diseases
DE102009034366A1 (en) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-methyleneoxyalkylene aryl derivatives, process for their preparation and their use for the treatment of diseases
DE102009034525A1 (en) 2009-07-21 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-aryl derivatives, process for their preparation and their use for the treatment of diseases
DE102009034526A1 (en) 2009-07-21 2011-02-10 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluoroethyl-estra-4,9 (10) -diene-11-ethynylphenyl derivatives, process for their preparation and their use for the treatment of diseases
DE102010007722A1 (en) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesterone receptor antagonist
DE102010007719A1 (en) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesterone receptor antagonist

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained

Also Published As

Publication number Publication date
HU9501019D0 (en) 1995-06-28
JPH07278017A (en) 1995-10-24
KR950031081A (en) 1995-12-18
AU1632695A (en) 1995-10-19
FR2718354A1 (en) 1995-10-13
HUT71468A (en) 1995-11-28
FI951683A0 (en) 1995-04-07
FI951683A (en) 1995-10-09
CN1116929A (en) 1996-02-21
EP0676203A1 (en) 1995-10-11
FR2718354B1 (en) 1996-05-03
CA2146600A1 (en) 1995-10-09

Similar Documents

Publication Publication Date Title
IL112029A (en) Raloxifine and related compounds for use as medicaments for the treatment of disorders associated with an excess of tachykinin
HU0800468D0 (en) Medicament for inhalation, canister and device containing the same
IL127189A0 (en) Compositions methods and devices for the transdermal delivery of drugs
HUP0002645A3 (en) Phospholipid containing pharmaceutical composition for treating sleep apnea and apparatus for enabling the administration thereof
HUP0001192A3 (en) The use of topiramate and its derivatives for the preparation of pharmaceutical compositions treating obesity
IL107978A0 (en) Mannitol derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
GR3004150T3 (en) Medicaments for the treatment or prevention of the withdrawal syndrome.
GB8900678D0 (en) Compositions for the prevention and medical treatment of parodonthopathy
ZA952058B (en) Use of compounds having an anti-glucocorticoid activity for the preparation of medicaments intended for the prevention or treatment of symptoms associated with the syndrome of spontaneous or precipitated withdrawal from narcotics or narcotic mixtures and the compositions containing them
HUP9802795A3 (en) Pharmaceutical compositions containing beta-adrenergic agent and anorectic agent for the treatment of corpulence
AU1197992A (en) The use of loperamide and related compounds for treatment of respiratory disease symptoms
GB8914060D0 (en) Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
CA2102072A1 (en) Combination preparation containing flupirtin and morphine for the treatment of pain and the prevention of morphine dependence
IL125598A0 (en) Mixtures which may be isolated from eugenia jambolana lamarck their preparation and use of these mixtures and some of their constituents as medications
IL107449A0 (en) Compositions and methods for reducing toxicity and increasing the efficacy of drugs
IL114128A0 (en) Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms
GB8914061D0 (en) Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
ZA925146B (en) Pharmaceutical agent for treatment of withdrawal symptoms.
CA2118512A1 (en) Agents for treating substance abuse disorders
GB8914062D0 (en) Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
NZ219557A (en) Synergistic pharmaceutical compositions containing nedocromil and an inhalation agent
IL114129A0 (en) Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms
HU0500865D0 (en) Use of teophyllin derivatives for the preparation of pharmaceutical compositions for the prevention and treatment of shock
IL105061A (en) Pharmaceutical compositions for the treatment of neurodegenerative diseases comprising VIP analogues and fragments thereof
IL91451A0 (en) Pharmaceutical compositions comprising azapiron compounds and their use in the treatment of addiction